News

XL880 is an orally bioavailable small molecule inhibitor of the MET and VEGF receptor tyrosine kinases that are involved in tumor cell growth, migration, and angiogenesis. The multi-center

Combigan has been developed for the reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension and is already marketed in Europe, Canada, Brazil and Australia.

The FDA’s Office of Generic Drugs has determined Ranbaxy’s simvastatin to be bioequivalent to the listed drug Zocor manufactured by Merck Research Laboratories. Total annualized market sales for

This approval was based upon the results of a large comparative trial for surgical site infection (SSI) in patients who have had colorectal surgery. “Given the high incidence

The transaction saw GSK purchase all outstanding CNS shares for approximately $566 million. According to GSK, CNS reported a 20% increase in sales in fiscal 2006 over the

However, the drugs label will also contain an unexpected warning that it can cause side effects such as heart problems. Invega contains paliperidone, the active ingredient derived from

The Navy and the FDA communicated following a meeting of the Blood Products Advisory Committee (BPAC). The BPAC voted against proceeding with the proposed phase IIb/III trial. Committee

The study compares two doses of Androxal, 12.5mg and 25mg, to both placebo and open-label Androgel, Solvay’s testosterone replacement cream. Repros said that Androxal, which is an oral

Post-operative ileus (POI) is a temporary impairment of gastrointestinal (GI) function and a common response to abdominal surgical procedures. The companies believe that because many postoperative patients cannot